long-term management of cll for improved outcomes
Published 2 years ago • 327 plays • Length 2:19Download video MP4
Download video MP3
Similar videos
-
1:43
long-term outcomes of the ifcg regimen for firstline treatment of patients with ighv-mutated cll
-
1:12
insights into the optimal management of cll: the importance of patient characteristics
-
8:33
boven regimen for previously untreated cll: long-term follow-up and mrd kinetics
-
1:29
the importance of treatment sequencing in cll
-
17:23
updates in cll: key clinical trials in the frontline and r/r setting, pre-clinical data and mrd
-
9:25
mgus diagnosis: a step-by-step approach
-
3:13
cll versus other leukemia types
-
2:18
tools to improve the outcomes of patients with cll affected by covid-19
-
7:55
clinical trials of fixed duration treatments & novel targets in cll
-
2:43
treatment sequencing options for recurrent cll
-
2:14
long-term follow-up results from the rathl trial: response-adapted treatment for advanced stage hl
-
3:29
how the management of cll is evolving
-
1:17
optimizing initial therapy in cll: time-limited, all-oral approaches
-
1:24
sequencing of btk inhibitors in cll
-
1:25
the management of cll in italy
-
0:53
the future of cll treatment
-
2:41
fixed-duration vs continuous therapy in cll
-
3:45
the treatment and management of cll across the globe
-
1:31
pembrolizumab plus avd in chl: long-term follow-up of a phase ii study
-
1:13
factors to consider when selecting between continuous and fixed-duration therapy in cll
-
2:22
improve study: mrd assessment as an endpoint to define treatment length and intensity in cll